Researcher
Peter Carmeliet
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology
- Disciplines (KU Leuven):Cardiac and vascular medicine
- See also: Peter Carmeliet (Flanders Institute for Biotechnology)
Affiliations
- Laboratory of Angiogenesis and Vascular Metabolism (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2012 → Today - Carmeliet Lab (Research group)
Responsible
From1 Jan 2017 → Today - Laboratory of Angiogenesis and Vascular Metabolism (VIB-KU Leuven) (Division)
Member
From1 Jan 2012 → Today - Centre for Molecular and Vascular Biology (Division)
Member
From1 Oct 1999 → 30 Sep 2005
Projects
1 - 10 of 110
- Angiogenesis and Vascular HeterogeneityFrom9 Jan 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Immunomodulatory role of graft endothelial cells to improve organ transplantationFrom30 Nov 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Demystifying the mystery genome for alternative immunotherapy targets: combining artificial intelligence-based discovery of immunomodulatory endothelial cell targets and in vivo target validation.From1 Oct 2022 → 30 Sep 2023Funding: BOF - postdoctoral mandates
- DEMYSTIFYING ALTERNATIVE IMMUNOTHERAPY MYSTERY TARGETS BY COMBINING ARTIFICIAL INTELLIGENCE- BASED TARGET DISCOVERY AND LARGER-SCALE TARGET VALIDATIONFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Immunomodulatory endothelial cells (IMECs): dissecting their immunosuppressive / im- munostimulatory features via nanoparticle-based gene silencing or overexpressionFrom26 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Validating novel AI-predicted targets for alternative cancer immunotherapyFrom20 Sep 2022 → TodayFunding: FWO fellowships, Foundations, funds and other with scientific goal
- Angiogenesis and Vascular HeterogeneityFrom19 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Metabolic and epigenetic interplay in neural progenitor cells: investigating neurodevelopmental disorders associated with impaired neural progenitor cell expansion (MEPIcephaly).From1 Jun 2022 → TodayFunding: FWO research project (including WEAVE projects)
- Imaging the invisible in preclinical models using magnetic particle imagingFrom1 May 2022 → TodayFunding: FWO Large scale research infrastructure
- Next-generation, multi-technology immune-monitoring and easy-access spectral flow cytometryFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
Publications
31 - 40 of 587
- PHGDH heterogeneity potentiates cancer cell dissemination and metastasis (vol 605. pg 747, 2022)(2022)
Authors: Margherita Demicco, Anke Vandekeere, Juan Fernandez Garcia, Carla Riera Domingo, David Nittner, Francesca Rizzollo, Panagiotis Karras, dorien Broekaert, Sofie Demeyer, Ayse Bassez, et al.
Pages: E8 - E8 - Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension(2022)
Authors: Laura De Rooij, Peter Carmeliet
Pages: 2519 - 2534 - Vasculogenesis in kidney organoids upon transplantation(2022)
Authors: Sébastien Dumas, Mila Borri, Peter Carmeliet
- Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers(2022)
Authors: Ali Talebi, Wout De Wispelaere, Regina Esi Mensimah Baiden-Amissah, Guy Eelen, Emanuele Berardi, Johan Swinnen, Peter Carmeliet, Diether Lambrechts, Sarah-Maria Fendt, Daniela Annibali, et al.
- Identification of vascular cues contributing to cancer cell stemness and function(2022)
Authors: Peter Carmeliet
Pages: 355 - 371 - Skeletal progenitors preserve proliferation and self-renewal upon inhibition of mitochondrial respiration by rerouting the TCA cycle(2022)
Authors: Shauni Loopmans, Steve Stegen, Guy Eelen, Peter Carmeliet, Bart Ghesquière, Bernard Thienpont, Sarah-Maria Fendt, Geert Carmeliet
- Endothelial cell heterogeneity and microglia regulons revealed by a pig cell landscape at single-cell level(2022)
Authors: Peter Carmeliet
- A YAP/TAZ-TEAD signalling module links endothelial nutrient acquisition to angiogenic growth(2022)
Authors: Guy Eelen, Peter Carmeliet
Pages: 672 - + - Tumor vessel co-option at single-cell resolution(2022)
Authors: Laure-Anne Teuwen, Peter Carmeliet
- PHGDH heterogeneity potentiates cancer cell dissemination and metastasis(2022)
Authors: David Nittner, Panagiotis Karras, Peter Carmeliet
Pages: 747 - +
Patents
1 - 10 of 10
- Carnitine palmitoyltransferase 1 inhibitors for inhibition of pathological angiogenesis (Inventor)
- Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor (Inventor)
- Inhibition of plgf to treat philadelphia chromosome positive leukemia (Inventor)
- Means and methods for treating lung hypoplasia (Inventor)
- Use of VEGF and homologues to treat neuron disorders (Inventor)
- Novel anti-PLGF antibody (Inventor)
- Anti-angiogenic therapy (Inventor)
- Responsiveness to angiogenesis inhibitors (Inventor)
- CARNITINE PALMITOYLTRANSFERASE 1 INHIBITORS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS (Inventor)
- GLUTAMINE SYNTHETASE INHIBITORS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS (Inventor)